CAS: 896723-44-7
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Farletuzumab REF: TM-T76720CAS: 896723-44-7 | SDS-PAGE:95% SEC-HPLC:95% | 346.00 €~3,647.00 € | Thu 24 Oct 24 |
 | Farletuzumab REF: 3D-CLA1219CAS: 896723-44-7 | - - - | To inquire | Tue 05 Nov 24 |
Farletuzumab
CAS:896723-44-7
Farletuzumab (MORAb-003), a humanized antibody, inhibits FRα-expressing cell growth for cancer research.
Purity:
SDS-PAGE:95% SEC-HPLC:95%
Color and Shape:
Solid
Ref: TM-T76720
| 1mg | 346.00 € | ||
| 5mg | 866.00 € | ||
| 10mg | 1,383.00 € | ||
| 25mg | 2,032.00 € | ||
| 50mg | 2,757.00 € | ||
| 100mg | 3,647.00 € |
Estimated delivery in United States, on Thursday 24 Oct 2024
Ref: 3D-CLA1219
| Undefined size | To inquire |
Estimated delivery in United States, on Tuesday 5 Nov 2024
